|
SETD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.98020505443242E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.36540001316865E-09 |
| Normal-vs-Stage2 |
3.70240000000521E-05 |
| Normal-vs-Stage3 |
2.12989625936189E-11 |
| Normal-vs-Stage4 |
7.00459690250455E-11 |
| Stage1-vs-Stage2 |
7.323800E-01 |
| Stage1-vs-Stage3 |
1.833520E-02 |
| Stage1-vs-Stage4 |
2.446000E-02 |
| Stage2-vs-Stage3 |
6.556500E-02 |
| Stage2-vs-Stage4 |
4.515800E-02 |
| Stage3-vs-Stage4 |
6.968800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50469636750472E-11 |
| Normal-vs-AfricanAmerican |
1.627670E-04 |
| Normal-vs-Asian |
2.70649999967176E-07 |
| Caucasian-vs-AfricanAmerican |
4.867000E-01 |
| Caucasian-vs-Asian |
1.779750E-01 |
| AfricanAmerican-vs-Asian |
9.393400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4911999999544E-06 |
| Normal-vs-Female |
1.99107397236276E-12 |
| Male-vs-Female |
1.421180E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38269999894192E-08 |
| Normal-vs-Age(41-60Yrs) |
8.1237017113267E-11 |
| Normal-vs-Age(61-80Yrs) |
1.07730047105292E-10 |
| Normal-vs-Age(81-100Yrs) |
5.565900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.614200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.165990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.968200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.502200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.232600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.326000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.790600E-04 |
| Classical-VS-Follicular |
5.743400E-01 |
| Classical-VS-Other |
2.719400E-01 |
| Classical-VS-Normal |
3.75690034637444E-10 |
| Tall-VS-Follicular |
2.629700E-04 |
| Tall-VS-Other |
6.062500E-03 |
| Tall-VS-Normal |
7.36632976838791E-12 |
| Follicular-VS-Other |
4.978600E-01 |
| Follicular-VS-Normal |
1.59615999999474E-05 |
| Other-VS-Normal |
1.670180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51189957722886E-10 |
| Normal-vs-N1 |
2.51400011919145E-10 |
| N0-vs-N1 |
6.004300E-02 |
|
|
